Medical Marijuana, Inc. Subsidiary HempMeds® Welcomes X Games World Record-Holding Skateboarder Italo Penarrubia as Newest Brand Ambassador

Medical Marijuana, Inc. Subsidiary HempMeds® Welcomes X Games World Record-Holding Skateboarder Italo Penarrubia as Brand Ambassador

SAN DIEGO, March 30, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® is proud to welcome X Games world record-holding skateboarder Italo Penarrubia as its newest brand ambassador.

“We are excited to bring Penarrubia on as a part of our team and it is heart-warming to know how much our products have helped him over the years. We believe his support and recognition will help us further educate athletes and the general public on the health and wellness benefits of hemp-based cannabidiol (CBD) products,” said HempMeds® CEO Raul Elizalde.

Penarrubia is a renowned skateboarder and has performed in several X Games competitions, including his most recent appearance in X Games Minneapolis in 2019. At the 2017 X Games in Minneapolis, he earned a world record for the highest SKB Big Air height ever recorded at the X Games. After spending several years training in the U.S., Penarrubia recently relocated back to Brazil to continue his career and raise his family.

“I have been using HempMeds’ CBD products for years to aid in recovery after long days of training,” said Penarrubia. “My goal is to help bridge the knowledge gap for athletes around the world that could benefit from using CBD but are afraid or unsure of how to use the products.”

To learn more about HempMeds®, please visit the Company online at

About HempMeds®
Founded in 2012, HempMeds® was the first company to bring hemp-based cannabidiol (CBD) oil products to market in the U.S. As a subsidiary of Medical Marijuana, Inc., HempMeds is the exclusive distributor for premium brands including Real Scientific Hemp Oil™ and Dixie Botanicals®, and operates in all 50 states and 40 countries. HempMeds® is the only company to have its CBD products listed in the Prescribers’ Digital Reference (PDR), the only company invited to speak to the World Health Organization and FDA on the benefits of CBD, and one of the first to be certified by the U.S. Hemp Authority. To learn more, please visit

About Medical Marijuana, Inc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.

Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at or by visiting To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.


Public Relations Contact:
Kathryn Brown
Account Supervisor
CMW Media
P. 858-264-6600
[email protected]

Investor Relations Contact:
P. (858) 283-4016
[email protected]